Caprock Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,429
| Closed | -$210K | – | 610 |
|
|
2021
Q4 | $210K | Buy |
+3,429
| New | +$210K | 0.02% | 527 |
|
|
2021
Q3 | – | Sell |
-2,566
| Closed | -$237K | – | 536 |
|
|
2021
Q2 | $237K | Sell |
2,566
-2,977
| -54% | -$275K | 0.02% | 446 |
|
|
2021
Q1 | $492K | Buy |
5,543
+843
| +18% | +$74.8K | 0.05% | 241 |
|
|
2020
Q4 | $438K | Sell |
4,700
-121
| -3% | -$11.3K | 0.05% | 251 |
|
|
2020
Q3 | $307K | Sell |
4,821
-397
| -8% | -$25.3K | 0.04% | 287 |
|
|
2020
Q2 | $272K | Sell |
5,218
-4,107
| -44% | -$214K | 0.04% | 301 |
|
|
2020
Q1 | $292K | Buy |
+9,325
| New | +$292K | 0.06% | 241 |
|